Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-05

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from individuals with brain inflammation and related neuroinflammatory conditions. Participants in the United States aged 2 years and older will provide self-reported health data, biometrics, and symptom diaries through the MyDataHelps™ app (branded as unhide® for this study). The goal is to create comprehensive longitudinal profiles to facilitate research into disease subtypes, causes, diagnostics, and potential treatments, as well as to identify potential participants for future optional studies. "Healthy" individuals without brain inflammation are also eligible to participate.

The digital health research platform used in this study was originally developed and designed by Solve M.E and was called SolveTogether. The Brain Inflammation Collaborative (BIC) expanded upon Solve M.E.'s work to include related diagnoses, pediatric participants, enhance symptom tracking, and more. BIC and Solve M.E. combined Solve Together and unhide®, to create The unhide® Solve Together Unified Platform in 2025.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

NCT01931644

All Diagnosed Health Conditions ADD/ADHD Alopecia Areata +58 more

COMPLETED

Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases

NCT06435468

Systemic Lupus Autoimmune Diseases Autoinflammatory Disease +1 more

RECRUITING NA

Dissemination of the Lupus Interactive Navigator

NCT02950714

Systemic Lupus Erythematosus

COMPLETED NA

Clinical Autoinflammatory Disease Cohort

NCT07126145

Still Disease Autoinflammatory Disease

NOT_YET_RECRUITING

Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus

NCT03746197

Lupus Erythematosus, Systemic

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The unhide® Project is sponsored by the Brain Inflammation Collaborative (BIC), a nonprofit organization dedicated to advancing understanding, diagnosis, and treatment of neuroinflammatory illness. This study will create a secure, long-term repository of demographic, health, lifestyle, biometric, and symptom data from individuals in the United States with brain inflammation and related conditions, as well as unaffected individuals. Data will be collected remotely through MyDataHelps™ by Care Evolution (rebranded as unhide®), a secure mobile and web-based platform enabling eConsent, survey completion, health record linkage, and optional symptom/activity tracking.

Eligible participants are U.S. residents aged 2 years and older, including both self-identified and physician-diagnosed individuals with infection-associated, autoimmune, neuroimmune, inflammatory gastrointestinal, and behavioral/mood disorders, as well as "healthy" individuals. There are minimal exclusion criteria: individuals living outside the U.S., wards of the state, and those with decisional impairment are ineligible. Pregnant women may participate, and prior or concurrent participation in other research studies is permitted.

The study will follow participants for 10 or more years, collecting self-reported health information, comorbidities, medical history, biometrics (e.g., heart rate, sleep, activity), and symptom data to generate comprehensive longitudinal health profiles. This data resource aims to accelerate translational research, identify disease subtypes, uncover causes and risk factors, support the development of diagnostic tests and treatments, and improve outcomes for individuals affected by neuroinflammation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-Acute COVID-19 Syndrome ME/CFS Rheumatic Arthritis Juvenile Rheumatoid Arthritis (JRA) Psoriatic Arthritis (PsA) Ankylosing Spondylitis (AS) Autoimmune Encephalitis Celiac Disease Celiac Disease in Children Chronic Lyme Disease Post-treatment Lyme Disease Syndrome Crohn's Disease Dysautonomia Anorexia Nervosa Bulimia Nervosa ARFID Avoidant / Restrictive Food Intake Disorder Ehlers Danlos Syndrome Endometriosis Fibromyalgia (FM) Long COVID Lupus Migraines Mast Cell Activation Syndrome Multiple Sclerosis Myalgic Encephalomyelitis (ME) Myasthenia Gravis, Generalized Myasthenia Gravis in Children Narcolepsy Obsessive Compulsive Disorder (OCD) PANDAS Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) POTS - Postural Orthostatic Tachycardia Syndrome General Anxiety Disorder, Social Anxiety Disorder PTSD - Post Traumatic Stress Disorder Psoriasis Traumatic Brain Injury Tourette's Syndrome Inflammatory Bowel Disease (IBD) Autoimmune Diseases Neurological Diseases or Conditions Psychiatric Disorder Sjogren's Syndrome Ulcerative Colitis and Crohn's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

People with brain inflammation and related neuroinflammatory conditions

No intervention will be administered.

No interventions assigned to this group

Healthy Controls

No intervention will be administered.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Participants may be either self-diagnosed, or diagnosed by a physician with the following conditions:

* Infection-associated chronic conditions such as Long COVID, chronic Lyme, myalgic encephalomyelitis (ME/CFS), and post-acute neuropsychiatric syndrome (PANS/PANDAS).
* Neuroimmune, developmental, autonomic, and neurological conditions like migraines, dysautonomia, POTS, multiple sclerosis, and autism spectrum disorder.
* Autoimmune diseases such as Lupus, Sjogren's Disease, rheumatoid arthritis, myasthenia gravis, ankylosing spondylitis, and related autoimmune conditions.

Inflammatory gastrointestinal conditions such as Crohn's Disease, Celiac Disease, and ulcerative colitis.

* Behavioral and mood disorders such as anxiety, depression, bipolar disorder, PTSD, eating disorders, OCD, and other related conditions.
* "Healthy" people (without brain inflammation), including unaffected individuals, unaffected individuals in the same household, and unaffected individuals who are married to relatives and family members.
* Have consistent internet access and a cell phone, tablet, or PC since this is an online or app-based platform that requires entering data and completing surveys.
* Currently live in the United States
* Be able to participate in English (stay tuned for updates about the Spanish language version)
* Be willing to share symptom and health data through the platform

Minimum Eligible Age

2 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes